This predictor can be complemented with CA 19.9 and amylase measured in the serum in the and tumor which has low sensitivity but high specificity Table 3 22.
Se complementa el estudio con CA 19,9 y amilasa en el tumor y séricos, con baja sensibilidad pero alta especificidad 22tabla 3.